NFE2L2 and hepatocellular carcinoma: Several Nrf2 inhibitors have been studied in the context of cancer therapy, as reviewed in Panieri and Saso, 2019 [227], including brusatol, a quassinoid compound extracted from Brucea javanica that was shown to deplete Nrf2 protein levels in mouse hepatoma cells [228].